List of Tables
Table 1. Global Hyperthermia Therapy for Cancer Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Hyperthermia Therapy for Cancer Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Hyperthermia Therapy for Cancer Market Competitive Situation by Manufacturers in 2025
Table 4. Global Hyperthermia Therapy for Cancer Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Hyperthermia Therapy for Cancer Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Hyperthermia Therapy for Cancer Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Hyperthermia Therapy for Cancer Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Hyperthermia Therapy for Cancer Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Hyperthermia Therapy for Cancer, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Hyperthermia Therapy for Cancer, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Hyperthermia Therapy for Cancer, Product Types and Applications
Table 12. Global Key Manufacturers of Hyperthermia Therapy for Cancer, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hyperthermia Therapy for Cancer Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hyperthermia Therapy for Cancer Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hyperthermia Therapy for Cancer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Hyperthermia Therapy for Cancer Sales by Region (Units), 2021–2026
Table 18. Global Hyperthermia Therapy for Cancer Sales Market Share by Region (2021–2026)
Table 19. Global Hyperthermia Therapy for Cancer Sales by Region (Units), 2027–2032
Table 20. Global Hyperthermia Therapy for Cancer Sales Market Share by Region (2027–2032)
Table 21. Global Hyperthermia Therapy for Cancer Revenue by Region (US$ Million), 2021–2026
Table 22. Global Hyperthermia Therapy for Cancer Revenue Market Share by Region (2021–2026)
Table 23. Global Hyperthermia Therapy for Cancer Revenue by Region (US$ Million), 2027–2032
Table 24. Global Hyperthermia Therapy for Cancer Revenue Market Share by Region (2027–2032)
Table 25. North America Hyperthermia Therapy for Cancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Hyperthermia Therapy for Cancer Sales by Country (Units), 2021–2026
Table 27. North America Hyperthermia Therapy for Cancer Sales by Country (Units), 2027–2032
Table 28. North America Hyperthermia Therapy for Cancer Revenue by Country (US$ Million), 2021–2026
Table 29. North America Hyperthermia Therapy for Cancer Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Hyperthermia Therapy for Cancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Hyperthermia Therapy for Cancer Sales by Country (Units), 2021–2026
Table 32. Europe Hyperthermia Therapy for Cancer Sales by Country (Units), 2027–2032
Table 33. Europe Hyperthermia Therapy for Cancer Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Hyperthermia Therapy for Cancer Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Hyperthermia Therapy for Cancer Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Hyperthermia Therapy for Cancer Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Hyperthermia Therapy for Cancer Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Hyperthermia Therapy for Cancer Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Hyperthermia Therapy for Cancer Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Hyperthermia Therapy for Cancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Hyperthermia Therapy for Cancer Sales by Country (Units), 2021–2026
Table 42. Latin America Hyperthermia Therapy for Cancer Sales by Country (Units), 2027–2032
Table 43. Latin America Hyperthermia Therapy for Cancer Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Hyperthermia Therapy for Cancer Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Hyperthermia Therapy for Cancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Hyperthermia Therapy for Cancer Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Hyperthermia Therapy for Cancer Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Hyperthermia Therapy for Cancer Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Hyperthermia Therapy for Cancer Revenue by Country (US$ Million), 2027–2032
Table 50. Global Hyperthermia Therapy for Cancer Sales (Units) by Type (2021–2026)
Table 51. Global Hyperthermia Therapy for Cancer Sales (Units) by Type (2027–2032)
Table 52. Global Hyperthermia Therapy for Cancer Sales Market Share by Type (2021–2026)
Table 53. Global Hyperthermia Therapy for Cancer Sales Market Share by Type (2027–2032)
Table 54. Global Hyperthermia Therapy for Cancer Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Hyperthermia Therapy for Cancer Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Hyperthermia Therapy for Cancer Revenue Market Share by Type (2021–2026)
Table 57. Global Hyperthermia Therapy for Cancer Revenue Market Share by Type (2027–2032)
Table 58. Global Hyperthermia Therapy for Cancer Price (US$/Unit) by Type (2021–2026)
Table 59. Global Hyperthermia Therapy for Cancer Price (US$/Unit) by Type (2027–2032)
Table 60. Global Hyperthermia Therapy for Cancer Sales (Units) by Application (2021–2026)
Table 61. Global Hyperthermia Therapy for Cancer Sales (Units) by Application (2027–2032)
Table 62. Global Hyperthermia Therapy for Cancer Sales Market Share by Application (2021–2026)
Table 63. Global Hyperthermia Therapy for Cancer Sales Market Share by Application (2027–2032)
Table 64. Global Hyperthermia Therapy for Cancer Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Hyperthermia Therapy for Cancer Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Hyperthermia Therapy for Cancer Revenue Market Share by Application (2021–2026)
Table 67. Global Hyperthermia Therapy for Cancer Revenue Market Share by Application (2027–2032)
Table 68. Global Hyperthermia Therapy for Cancer Price (US$/Unit) by Application (2021–2026)
Table 69. Global Hyperthermia Therapy for Cancer Price (US$/Unit) by Application (2027–2032)
Table 70. Pyrexar Medical Company Information
Table 71. Pyrexar Medical Description and Business Overview
Table 72. Pyrexar Medical Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pyrexar Medical Hyperthermia Therapy for Cancer Product
Table 74. Pyrexar Medical Recent Developments/Updates
Table 75. Oncotherm Company Information
Table 76. Oncotherm Description and Business Overview
Table 77. Oncotherm Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Oncotherm Hyperthermia Therapy for Cancer Product
Table 79. Oncotherm Recent Developments/Updates
Table 80. Andromedic Company Information
Table 81. Andromedic Description and Business Overview
Table 82. Andromedic Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Andromedic Hyperthermia Therapy for Cancer Product
Table 84. Andromedic Recent Developments/Updates
Table 85. Yamamoto Vinita Company Information
Table 86. Yamamoto Vinita Description and Business Overview
Table 87. Yamamoto Vinita Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Yamamoto Vinita Hyperthermia Therapy for Cancer Product
Table 89. Yamamoto Vinita Recent Developments/Updates
Table 90. Med-Logix Company Information
Table 91. Med-Logix Description and Business Overview
Table 92. Med-Logix Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Med-Logix Hyperthermia Therapy for Cancer Product
Table 94. Med-Logix Recent Developments/Updates
Table 95. Thermofield Company Information
Table 96. Thermofield Description and Business Overview
Table 97. Thermofield Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Thermofield Hyperthermia Therapy for Cancer Product
Table 99. Thermofield Recent Developments/Updates
Table 100. Celsius42 Company Information
Table 101. Celsius42 Description and Business Overview
Table 102. Celsius42 Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Celsius42 Hyperthermia Therapy for Cancer Product
Table 104. Celsius42 Recent Developments/Updates
Table 105. Dongseo Medicare Company Information
Table 106. Dongseo Medicare Description and Business Overview
Table 107. Dongseo Medicare Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Dongseo Medicare Hyperthermia Therapy for Cancer Product
Table 109. Dongseo Medicare Recent Developments/Updates
Table 110. ThermaSolutions Company Information
Table 111. ThermaSolutions Description and Business Overview
Table 112. ThermaSolutions Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. ThermaSolutions Hyperthermia Therapy for Cancer Product
Table 114. ThermaSolutions Recent Developments/Updates
Table 115. Verthermia Company Information
Table 116. Verthermia Description and Business Overview
Table 117. Verthermia Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Verthermia Hyperthermia Therapy for Cancer Product
Table 119. Verthermia Recent Developments/Updates
Table 120. Combat Medical Company Information
Table 121. Combat Medical Description and Business Overview
Table 122. Combat Medical Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Combat Medical Hyperthermia Therapy for Cancer Product
Table 124. Combat Medical Recent Developments/Updates
Table 125. Hydrosun Company Information
Table 126. Hydrosun Description and Business Overview
Table 127. Hydrosun Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Hydrosun Hyperthermia Therapy for Cancer Product
Table 129. Hydrosun Recent Developments/Updates
Table 130. RanD Biotech Company Information
Table 131. RanD Biotech Description and Business Overview
Table 132. RanD Biotech Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. RanD Biotech Hyperthermia Therapy for Cancer Product
Table 134. RanD Biotech Recent Developments/Updates
Table 135. Shenzhen ET Medical Technology Company Information
Table 136. Shenzhen ET Medical Technology Description and Business Overview
Table 137. Shenzhen ET Medical Technology Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Shenzhen ET Medical Technology Hyperthermia Therapy for Cancer Product
Table 139. Shenzhen ET Medical Technology Recent Developments/Updates
Table 140. Jiangsu Nova Medical Equipment Company Information
Table 141. Jiangsu Nova Medical Equipment Description and Business Overview
Table 142. Jiangsu Nova Medical Equipment Hyperthermia Therapy for Cancer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Jiangsu Nova Medical Equipment Hyperthermia Therapy for Cancer Product
Table 144. Jiangsu Nova Medical Equipment Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Hyperthermia Therapy for Cancer Distributors List
Table 148. Hyperthermia Therapy for Cancer Customers List
Table 149. Hyperthermia Therapy for Cancer Market Trends
Table 150. Hyperthermia Therapy for Cancer Market Drivers
Table 151. Hyperthermia Therapy for Cancer Market Challenges
Table 152. Hyperthermia Therapy for Cancer Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hyperthermia Therapy for Cancer
Figure 2. Global Hyperthermia Therapy for Cancer Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Hyperthermia Therapy for Cancer Market Share by Type: 2025 & 2032
Figure 4. Superficial Hyperthermia Product Picture
Figure 5. Deep Regional Hyperthermia Product Picture
Figure 6. Global Hyperthermia Therapy for Cancer Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Hyperthermia Therapy for Cancer Market Share by Application: 2025 & 2032
Figure 8. Breast Cancer
Figure 9. Cervical Cancer
Figure 10. Soft Tissue Sarcoma
Figure 11. Melanoma
Figure 12. Others
Figure 13. Global Hyperthermia Therapy for Cancer Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Hyperthermia Therapy for Cancer Market Size (US$ Million), 2021–2032
Figure 15. Global Hyperthermia Therapy for Cancer Sales (Units), 2021–2032
Figure 16. Global Hyperthermia Therapy for Cancer Average Price (US$/Unit), 2021–2032
Figure 17. Hyperthermia Therapy for Cancer Report Years Considered
Figure 18. Hyperthermia Therapy for Cancer Sales Share by Manufacturers in 2025
Figure 19. Global Hyperthermia Therapy for Cancer Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Hyperthermia Therapy for Cancer Players: Market Share by Revenue in Hyperthermia Therapy for Cancer in 2025
Figure 21. Hyperthermia Therapy for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Hyperthermia Therapy for Cancer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Hyperthermia Therapy for Cancer Sales Market Share by Country (2021–2032)
Figure 24. North America Hyperthermia Therapy for Cancer Revenue Market Share by Country (2021–2032)
Figure 25. United States Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Hyperthermia Therapy for Cancer Sales Market Share by Country (2021–2032)
Figure 28. Europe Hyperthermia Therapy for Cancer Revenue Market Share by Country (2021–2032)
Figure 29. Germany Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Hyperthermia Therapy for Cancer Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Hyperthermia Therapy for Cancer Revenue Market Share by Region (2021–2032)
Figure 36. China Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Hyperthermia Therapy for Cancer Sales Market Share by Country (2021–2032)
Figure 44. Latin America Hyperthermia Therapy for Cancer Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Hyperthermia Therapy for Cancer Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Hyperthermia Therapy for Cancer Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Hyperthermia Therapy for Cancer Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Hyperthermia Therapy for Cancer by Type (2021–2032)
Figure 55. Global Revenue Market Share of Hyperthermia Therapy for Cancer by Type (2021–2032)
Figure 56. Global Hyperthermia Therapy for Cancer Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Hyperthermia Therapy for Cancer by Application (2021–2032)
Figure 58. Global Revenue Market Share of Hyperthermia Therapy for Cancer by Application (2021–2032)
Figure 59. Global Hyperthermia Therapy for Cancer Price (US$/Unit) by Application (2021–2032)
Figure 60. Hyperthermia Therapy for Cancer Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
